These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
639 related articles for article (PubMed ID: 23334168)
1. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Salvati A; Pitek AS; Monopoli MP; Prapainop K; Bombelli FB; Hristov DR; Kelly PM; Åberg C; Mahon E; Dawson KA Nat Nanotechnol; 2013 Feb; 8(2):137-43. PubMed ID: 23334168 [TBL] [Abstract][Full Text] [Related]
2. Chiral Surface of Nanoparticles Determines the Orientation of Adsorbed Transferrin and Its Interaction with Receptors. Wang X; Wang M; Lei R; Zhu SF; Zhao Y; Chen C ACS Nano; 2017 May; 11(5):4606-4616. PubMed ID: 28460159 [TBL] [Abstract][Full Text] [Related]
3. Nanocrystal facet modulation to enhance transferrin binding and cellular delivery. Qi Y; Zhang T; Jing C; Liu S; Zhang C; Alvarez PJJ; Chen W Nat Commun; 2020 Mar; 11(1):1262. PubMed ID: 32152269 [TBL] [Abstract][Full Text] [Related]
4. Fattigation-platform nanoparticles using apo-transferrin stearic acid as a core for receptor-oriented cancer targeting. Amin HH; Meghani NM; Park C; Nguyen VH; Tran TT; Tran PH; Lee BJ Colloids Surf B Biointerfaces; 2017 Nov; 159():571-579. PubMed ID: 28854413 [TBL] [Abstract][Full Text] [Related]
5. In situ characterization of nanoparticle biomolecular interactions in complex biological media by flow cytometry. Lo Giudice MC; Herda LM; Polo E; Dawson KA Nat Commun; 2016 Nov; 7():13475. PubMed ID: 27845346 [TBL] [Abstract][Full Text] [Related]
6. Tumor-targeting transferrin nanoparticles for systemic polymerized siRNA delivery in tumor-bearing mice. Yhee JY; Lee SJ; Lee S; Song S; Min HS; Kang SW; Son S; Jeong SY; Kwon IC; Kim SH; Kim K Bioconjug Chem; 2013 Nov; 24(11):1850-60. PubMed ID: 24107100 [TBL] [Abstract][Full Text] [Related]
7. Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles. Movassaghian S; Xie Y; Hildebrandt C; Rosati R; Li Y; Kim NH; Conti DS; da Rocha SR; Yang ZQ; Merkel OM Mol Pharm; 2016 Aug; 13(8):2605-21. PubMed ID: 27223606 [TBL] [Abstract][Full Text] [Related]
8. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells. Nag M; Gajbhiye V; Kesharwani P; Jain NK Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697 [TBL] [Abstract][Full Text] [Related]
9. Transferrin- and folate-modified, double-targeted nanocarriers for gene delivery. Jing F; Li D; Xu W; Liu Y; Wang K; Sui Z Pharm Biol; 2014 May; 52(5):570-4. PubMed ID: 24256214 [TBL] [Abstract][Full Text] [Related]
10. Transferrin coated nanoparticles: study of the bionano interface in human plasma. Pitek AS; O'Connell D; Mahon E; Monopoli MP; Baldelli Bombelli F; Dawson KA PLoS One; 2012; 7(7):e40685. PubMed ID: 22829881 [TBL] [Abstract][Full Text] [Related]
11. Influence of ligands property and particle size of gold nanoparticles on the protein adsorption and corresponding targeting ability. Xiao W; Xiong J; Zhang S; Xiong Y; Zhang H; Gao H Int J Pharm; 2018 Mar; 538(1-2):105-111. PubMed ID: 29341915 [TBL] [Abstract][Full Text] [Related]
12. Rational Design of a Transferrin-Binding Peptide Sequence Tailored to Targeted Nanoparticle Internalization. Santi M; Maccari G; Mereghetti P; Voliani V; Rocchiccioli S; Ucciferri N; Luin S; Signore G Bioconjug Chem; 2017 Feb; 28(2):471-480. PubMed ID: 27977155 [TBL] [Abstract][Full Text] [Related]
13. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex. Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889 [TBL] [Abstract][Full Text] [Related]
14. Physicochemical and biological characterization of targeted, nucleic acid-containing nanoparticles. Bartlett DW; Davis ME Bioconjug Chem; 2007; 18(2):456-68. PubMed ID: 17326672 [TBL] [Abstract][Full Text] [Related]
15. Engineering Mesoporous Silica Nanoparticles for Targeted Alpha Therapy against Breast Cancer. Pallares RM; Agbo P; Liu X; An DD; Gauny SS; Zeltmann SE; Minor AM; Abergel RJ ACS Appl Mater Interfaces; 2020 Sep; 12(36):40078-40084. PubMed ID: 32805833 [TBL] [Abstract][Full Text] [Related]
16. Quantitative analysis of the protein corona on FePt nanoparticles formed by transferrin binding. Jiang X; Weise S; Hafner M; Röcker C; Zhang F; Parak WJ; Nienhaus GU J R Soc Interface; 2010 Feb; 7 Suppl 1(Suppl 1):S5-S13. PubMed ID: 19776149 [TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-protein complexes mimicking corona formation in ocular environment. Jo DH; Kim JH; Son JG; Dan KS; Song SH; Lee TG; Kim JH Biomaterials; 2016 Dec; 109():23-31. PubMed ID: 27648757 [TBL] [Abstract][Full Text] [Related]
18. Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells. Huang RK; Steinmetz NF; Fu CY; Manchester M; Johnson JE Nanomedicine (Lond); 2011 Jan; 6(1):55-68. PubMed ID: 21182418 [TBL] [Abstract][Full Text] [Related]
19. The protein corona suppresses the cytotoxic and pro-inflammatory response in lung epithelial cells and macrophages upon exposure to nanosilica. Leibe R; Hsiao IL; Fritsch-Decker S; Kielmeier U; Wagbo AM; Voss B; Schmidt A; Hessman SD; Duschl A; Oostingh GJ; Diabaté S; Weiss C Arch Toxicol; 2019 Apr; 93(4):871-885. PubMed ID: 30838431 [TBL] [Abstract][Full Text] [Related]
20. Implications of protein corona on physico-chemical and biological properties of magnetic nanoparticles. Yallapu MM; Chauhan N; Othman SF; Khalilzad-Sharghi V; Ebeling MC; Khan S; Jaggi M; Chauhan SC Biomaterials; 2015 Apr; 46():1-12. PubMed ID: 25678111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]